Snow-covered streets. Festive markets. Unforgettable memories.
There is something special about a winter holiday. The crisp air, the sparkling lights and the excitement of exploring somewhere new.
But a long-awaited trip can quickly feel different when a sore throat, runny nose or cough interrupts your plans. As you prepare your itinerary and pack your warmest clothes, give your health a place on the checklist too.
Your winter preparations could start somewhere unexpected: your gut.
A change of scenery. A challenge for your defences.

In many destinations, winter is a season when respiratory infections such as influenza and RSV become more common. Cold, dry conditions can favour transmission of certain viruses, while crowded indoor spaces offer more opportunities for exposure.
Early departures, overnight flights and late-night sightseeing can also disrupt sleep, meals and rest.
Make looking after your body part of the journey.
Your lungs have an unexpected connection. Your gut.
Your gut microbiome – the community of microorganisms living in your digestive tract – interacts closely with your immune system. Through the gut-lung axis, immune signals and substances produced by gut bacteria can influence immune activity beyond digestion. [1]
Some beneficial bacteria break down dietary fibre to produce short-chain fatty acids. These help maintain the gut lining and participate in regulating immune activity.
Gut health matters. Beyond digestion.

Conceptual illustration of the gut-lung connection; not an anatomical pathway map.
A healthy microbial community supports digestion, the intestinal barrier and communication with the immune system. When this ecosystem is disrupted, an imbalance known as gut dysbiosis can occur.
Research in people with COVID-19 identified changes in the gut microbiome, including a loss of certain beneficial bacteria. These observations helped inform the development of SIM01. [2]
Precision begins with understanding the microbiome.
Developed through research at The Chinese University of Hong Kong, SIM01 is a targeted synbiotic formula combining three selected probiotics with three prebiotics. Its formulation was informed by differences observed between the gut microbiomes of people with COVID-19 and healthy individuals. [2]
What does the research show?
Infection-related outcomes. A randomised, double-blind study involving people receiving COVID-19 vaccination reported fewer new infections among participants receiving SIM01 than among controls during follow-up. [3]
Post-viral recovery. A separate randomised, placebo-controlled trial published in The Lancet Infectious Diseases reported greater alleviation of selected persistent symptoms following COVID-19 after six months, including fatigue, memory difficulties, concentration problems and gastrointestinal upset. [4]
Different studies examined different populations and outcomes. These findings do not establish that SIM01 prevents every cold or respiratory infection during a holiday.
More memories. Make room for wellness.

A walk through a snowy town. A festive dinner with family. Your first glimpse of a mountain landscape. Looking after your health begins before those moments arrive.
Make time for sleep. Give yourself room to rest around long journeys and busy sightseeing days.
Eat for your gut. Include vegetables, fruit, whole grains and other fibre-rich foods.
Keep sensible precautions. Practise good hand hygiene and consider a well-fitting mask in crowded indoor spaces.
Review vaccinations. Check recommendations for your destination and personal health needs.
Pack for the cold. Prepare from within.
G-NiiB SIM01 combines three selected probiotics with three prebiotics. A research-driven option for supporting your gut microbiome as part of your overall wellness routine.
Prepare from within.

3 selected probiotics + 3 prebiotics
Available in 7-sachet and 28-sachet packs. Use according to the product label.
SIM01 is not a substitute for vaccination, infection-prevention measures or medical treatment. Individual results may vary.
Research and further reading
[1] CUHK: Short-chain fatty acids, the gut microbiome and antiviral immunity. Read study
[2] Gut microbiota-derived synbiotic formula SIM01 as a novel adjuvant therapy for COVID-19: an open-label pilot study. Read study
[3] CUHK clinical study report: SIM01 and infection-related outcomes (2022). Read study
[4] RECOVERY trial. The Lancet Infectious Diseases (2024). Read study